Christopher Codeanne

Christopher Codeanne

Chief Financial Officer

Chris Codeanne, OPM's Chief Financial Officer, has over 24 years of management, operations, finance, and transaction related experience. Mr. Codeanne was most recently the COO and CFO and a member of the Board of Premier Research, an international professional services organization with over 1,000 employees providing clinical development services to the pharmaceutical, biotechnology and medical device industries.

Prior to Premier Research, Mr. Codeanne held the position of Chief Financial Officer at three publically traded, private equity and/or venture backed, specialized international clinical development organizations, Oncopartners (where he also served as COO), Averion International Corporation, and SCIREX Corporation (which grew from $10M to $150M in revenues during his tenure). Mr. Codeanne has led various transformative acquisitions, divestitures and capital raising initiatives and has been an instrumental participant in successfully growing early stage businesses.

Mr. Codeanne was a member of the Board of Directors, Audit Committee Chairman, Compensation Committee and member of Nominating Committee of Cornerstone Therapeutics Inc. (NASDAQ: CRTX), a specialty pharmaceutical company. He also and had previously served as a member of the Special Committee charged with evaluating and consummating the ultimate sale of the business.

Mr. Codeanne obtained an MBA from the University of Connecticut with a concentration in finance, and a bachelor of science degree in accounting from Fairfield University. He is a member of the American Institute of Certified Public Accountants.